{
  "target": "TL1A",
  "slug": "tl1a-ibd",
  "last_reviewed": "2026-02-10",
  "catalysts": [
    {
      "date": "2025-02",
      "date_display": "Feb 2025",
      "company": "Sanofi/Teva",
      "asset": "Duvakitug",
      "description": "Phase 2b detailed results presented at ECCO 2025",
      "outcome": "Positive — met primary endpoints in UC (47.8% remission high-dose) and CD"
    },
    {
      "date": "2025-05",
      "date_display": "May 2025",
      "company": "Merck",
      "asset": "Tulisokibart",
      "description": "APOLLO-CD Phase 2 trial completed",
      "outcome": "Completed — well tolerated through 50 weeks"
    },
    {
      "date": "2025-09",
      "date_display": "H2 2025",
      "company": "Sanofi/Teva",
      "asset": "Duvakitug",
      "description": "Phase 3 programs initiated: SUNSCAPE (UC) and STARSCAPE (CD)",
      "outcome": "Initiated — enrolling"
    },
    {
      "date": "2025-10",
      "date_display": "H2 2025",
      "company": "Merck",
      "asset": "Tulisokibart",
      "description": "Expanded into Phase 2b for HS, r-axSpA, and RA",
      "outcome": "3 new Phase 2b trials initiated"
    },
    {
      "date": "2025-12",
      "date_display": "Q4 2025",
      "company": "Sanofi/Teva",
      "asset": "Duvakitug",
      "description": "$500M development milestone triggered by Phase 3 initiation",
      "outcome": "Milestone paid"
    },
    {
      "date": "2026-03",
      "date_display": "Q1 2026",
      "company": "Merck",
      "asset": "Tulisokibart",
      "description": "ATLAS-UC Phase 3 primary completion expected"
    },
    {
      "date": "2026-06",
      "date_display": "2026",
      "company": "Roche",
      "asset": "Afimkibart",
      "description": "Phase 3 readout in UC"
    },
    {
      "date": "2026-11",
      "date_display": "H2 2026",
      "company": "Merck",
      "asset": "Tulisokibart",
      "description": "ATLAS-UC Phase 3 preliminary results expected"
    },
    {
      "date": "2027-06",
      "date_display": "2027+",
      "company": "Sanofi/Teva",
      "asset": "Duvakitug",
      "description": "SUNSCAPE & STARSCAPE Phase 3 data readouts"
    },
    {
      "date": "2029-06",
      "date_display": "2029",
      "company": "Merck",
      "asset": "Tulisokibart",
      "description": "ARES-CD Phase 3 primary completion expected"
    }
  ]
}
